Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-25-001669
Filing Date
2025-03-17
Accepted
2025-03-17 17:22:56
Documents
73
Period of Report
2025-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JAN 2025 pharmacyte_i10q-013125.htm   iXBRL 10-Q 989636
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER pharmacyte_ex3101.htm EX-31.1 8993
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER pharmacyte_ex3102.htm EX-31.2 8979
4 CERTIFICATION pharmacyte_ex3201.htm EX-32.1 4349
5 CERTIFICATION pharmacyte_ex3202.htm EX-32.2 4250
  Complete submission text file 0001683168-25-001669.txt   5304349

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pmcb-20250131.xsd EX-101.SCH 47594
7 XBRL CALCULATION FILE pmcb-20250131_cal.xml EX-101.CAL 54718
8 XBRL DEFINITION FILE pmcb-20250131_def.xml EX-101.DEF 209029
9 XBRL LABEL FILE pmcb-20250131_lab.xml EX-101.LAB 361852
10 XBRL PRESENTATION FILE pmcb-20250131_pre.xml EX-101.PRE 322176
76 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_i10q-013125_htm.xml XML 654610
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-40699 | Film No.: 25745685
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)